Company or ticker...

Company or ticker...

BioTech

Travere Therapeutics

Travere Therapeutics develops and commercializes therapies for rare kidney and metabolic diseases, aiming to provide life‑changing treatments for patients with serious unmet medical needs.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

TVTX

2.7B

6.0

n/a

-22.30%

Key Facts

M. Cap

PS

PE

YTD

2.7B

6.0

n/a

-22.30%

10MA

20MA

50MA

200MA

$TVTX